Retraction notice to "Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways" Biochimica et Biophysica Acta [1830 (10) 4907-4916];Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 10, 2013, Pages 4907-4916

  Yuan, Yi ^a   Cui, Shu Xiang ^b   Wang, Yan ^c   Ke, Han Ni ^a   Wang, Rui Qi ^a   Lou, Hong Xiang ^a   Gao, Zu Hua ^d,e   Qu, Xian Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d MCGILL UNIVERSITY   (Canada)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acetyl 11 keto beta boswellic acid (AKBA); Anti inflammation; Apoptosis; Aspirin; Colon adenocarcinoma; Toxicity

Indexed keywords

11 OXO BETA BOSWELLIC ACID; ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ARACHIDONATE 5 LIPOXYGENASE; ASPARTATE AMINOTRANSFERASE; ATM PROTEIN; CHECKPOINT KINASE 1; CYCLIN D; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLOOXYGENASE 2; CYTOCHROME C; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; PROCASPASE 9; PROTEIN KINASE B; PROTEIN P53; RAF PROTEIN; TELOMERIC REPEAT BINDING FACTOR 2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER INHIBITION; CANCER PREVENTION; CLONOGENIC ASSAY; COLON ADENOCARCINOMA; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; G1 PHASE CELL CYCLE CHECKPOINT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; TOXICITY TESTING; TUMOR VOLUME; WEIGHT REDUCTION; WESTERN BLOTTING;

MUS;

EID: 84884692508     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.11.002     Document Type: Erratum

References (46)

1. L.N. Kwong, and W.F. Dove APC and its modifiers in colon cancer Adv. Exp. Med. Biol. 656 2009 85 106
2. D. Wang, J.R. Mann, and R.N. DuBois WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth Cell Cycle 3 2004 1512 1515 (Pubitemid 40521402)
3. A. Manzano, and P. Pérez-Segura Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention? Sci. World J. 2012 2012 327341
4. P.M. Rothwell, M. Wilson, J.F. Price, J.F. Belch, T.W. Meade, and Z. Mehta Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials Lancet 379 2012 1591 1601
5. J. Cuzick, F. Otto, J.A. Baron, P.H. Brown, J. Burn, P. Greenwald, J. Jankowski, C. La, F. Vecchia, H.J. Meyskens, and M. Thun Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement Lancet Oncol. 10 2009 501 507
6. R.S. Sandler, S. Halabi, J.A. Baron, S. Budinger, E. Paskett, R. Keresztes, N. Petrelli, J.M. Pipas, D.D. Karp, C.L. Loprinzi, G. Steinbach, and R. Schilsky A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer N. Engl. J. Med. 348 2003 883 890 (Pubitemid 36297996)
7. J.A. Baron, B.F. Cole, R.S. Sandler, R.W. Haile, D. Ahnen, R. Bresalier, G. McKeown-Eyssen, R.W. Summers, R. Rothstein, C.A. Burke, D.C. Snover, T.R. Church, J.I. Allen, M. Beach, G.J. Beck, J.H. Bond, T. Byers, E.R. Greenberg, J.S. Mandel, N. Marcon, L.A. Mott, L. Pearson, F. Saibil, and R.U. van Stolk A randomized trial of aspirin to prevent colorectal adenomas N. Engl. J. Med. 348 2003 891 899 (Pubitemid 36297997)
8. X. Garcia-Albeniz, and A.T. Chan Aspirin for the prevention of colorectal cancer Best Pract. Res. Clin. Gastroenterol. 25 2011 461 472
9. S. Singh, A. Khajuria, S.C. Taneja, R.K. Johri, J. Singh, and G.N. Qazi Boswellic acids: a leukotriene inhibitor also effective through topical application in inflammatory disorders Phytomedicine 15 2008 400 407
10. K. Sengupta, J.N. Kolla, A.V. Krishnaraju, N. Yalamanchili, C.V. Rao, T. Golakoti, S. Raychaudhuri, and S.P. Raychaudhuri Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract Mol. Cell. Biochem. 354 2011 189 197
11. M. Lu, L. Xia, H. Hua, and Y. Jing Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells Cancer Res. 68 2008 1180 1186 (Pubitemid 351272237)
12. U. Siemoneit, B. Hofmann, N. Kather, T. Lamkemeyer, J. Madlung, L. Franke, G. Schneider, J. Jauch, D. Poeckel, and O. Werz Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids Biochem. Pharmacol. 75 2008 503 513 (Pubitemid 350298477)
13. A. Moussaieff, E. Shohami, Y. Kashman, E. Fride, M.L. Schmitz, F. Renner, B.L. Fiebich, E. Munoz, Y. Ben-Neriah, and R. Mechoulam Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation Mol. Pharmacol. 72 2007 1657 1664 (Pubitemid 350146103)
14. H.P. Liu, Z.H. Gao, S.X. Cui, Y. Wang, B.Y. Li, H.X. Lou, and X.J. Qu Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta- boswellic acid (AKBA) in APC(Min/+) mice Int. J. Cancer 132 2012 2667 2681
15. H.Q. Yuan, F. Kong, X.L. Wang, C.Y. Young, X.Y. Hu, and H.X. Lou Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells Biochem. Pharmacol. 75 2008 2112 2121
16. X.J. Qu, J.L. Yang, P.J. Russell, and D. Goldstein Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment J. Urol. 172 2004 733 738 (Pubitemid 38900251)
17. M. Chhavi, M.P. Saxena, S. Negi, P.K. Singh, U. Singh, and M.L. Singh Bhatt, DNA content can improve the detection and prognosis of carcinoma of the cervix Biosci. Trends 4 2010 103 109
18. B. Yue, C.R. Zhao, H.M. Xu, Y.Y. Li, Y.N. Cheng, H.N. Ke, Y. Yuan, R.Q. Wang, Y.Q. Shi, H.X. Lou, and X.J. Qu Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: in vitro and in vivo studies Biochim. Biophys. Acta 1830 2013 2194 2203
19. B. Yue, Y.S. Zhang, H.M. Xu, C.R. Zhao, Y.Y. Li, Y.Z. Qin, R.Q. Wang, D. Sun, Y. Yuan, H.X. Lou, and X.J. Qu Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way Cancer Lett. 328 2013 104 113
20. M. Bishnoi, C.S. Patil, A. Kumar, and S.K. Kulkarni Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid Indian J. Exp. Biol. 44 2006 128 132 (Pubitemid 43219168)
21. O.J. Sansom, L.A. Stark, M.G. Dunlop, and A.R. Clarke Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice Cancer Res. 61 2001 7060 7064 (Pubitemid 32946497)
22. M.A. Hossain, D.H. Kim, J.Y. Jang, Y.J. Kang, J.H. Yoon, J.O. Moon, H.Y. Chung, G.Y. Kim, Y.H. Choi, B.L. Copple, and N.D. Kim Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo Int. J. Oncol. 40 2012 1636 1642
23. F. Liu, K. Bardhan, D. Yang, M. Thangaraju, V. Ganapathy, J.L. Waller, G.B. Liles, J.R. Lee, and K. Liu NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression J. Biol. Chem. 287 2012 25530 25540
24. H. Guillen-Ahlers, M.A. Suckow, F.J. Castellino, and V.A. Ploplis Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden PLoS One 5 2010 e9070
25. A. Kaidi, A.C. Williams, and C. Paraskeva Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia Nat. Cell Biol. 9 2007 210 217 (Pubitemid 46420864)
26. T.A. Ullman, and S.H. Itzkowitz Intestinal inflammation and cancer Gastroenterology 140 2011 1807 1816
27. B.B. Aggarwal, S. Shishodia, S.K. Sandur, M.K. Pandey, and G. Sethi Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72 2006 1605 1621 (Pubitemid 44666739)
28. M. De Rosa, R.J. Dourisboure, G. Morelli, A. Graziano, A. Gutiérrez, S. Thibodeau, K. Halling, K.C. Avila, F. Duraturo, E.J. Podesta, P. Izzo, and A.R. Solano First genotype characterization of Argentinean FAP patients: identification of 14 novel APC mutations Hum. Mutat. 23 2004 523 524
29. F. Balkwill Tumour necrosis factor and cancer Nat. Rev. Cancer 9 2009 361 371
30. T. Kuno, Y. Hatano, H. Tomita, A. Hara, Y. Hirose, A. Hirata, H. Mori, M. Terasaki, S. Masuda, and T. Tanaka Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice Carcinogenesis 34 2013 361 369
31. J.H. Oh, M.C. Cho, J.H. Kim, S.Y. Lee, H.J. Kim, E.S. Park, J.O. Ban, J.W. Kang, D.H. Lee, J.H. Shim, S.B. Han, D.C. Moon, Y.H. Park, D.Y. Yu, J.M. Kim, S.H. Kim, D.Y. Yoon, and J.T. Hong IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals Oncogene 30 2011 3345 3359
32. E.R. Greene, S. Huang, C.N. Serhan, and D. Panigrahy Regulation of inflammation in cancer by eicosanoids Prostaglandins Other Lipid Mediat. 96 2011 27 36
33. K. Zins, D. Abraham, M. Sioud, and S. Aharinejad Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway Cancer Res. 67 2007 1038 1045
34. B.B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword Nat. Rev. Immunol. 3 2003 745 756 (Pubitemid 41070815)
35. M.J. Wolf, G.M. Seleznik, N. Zeller, and M. Heikenwalder The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development Oncogene 29 2010 5006 5018
36. S. Luqman, and J.M. Pezzuto NFκB: a promising target for natural products in cancer chemoprevention Phytother. Res. 24 2010 949 963
37. G. Shen, T.O. Khor, R. Hu, S. Yu, S. Nair, C.T. Ho, B.S. Reddy, M.T. Huang, H.L. Newmark, and A.N. Kong Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse Cancer Res. 67 2007 9937 9944 (Pubitemid 47621243)
38. W. Han, and H.W. Lo Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations Cancer Lett. 318 2012 124 134
39. K.L. Mueller, K. Powell, J.M. Madden, S.T. Eblen, and J.L. Boerner EGFR tyrosine 845 phosphorylation-dependent proliferation and transformation of breast cancer cells require activation of p38 MAPK Transl. Oncol. 5 2012 327 334
40. H. Shen, W. Xu, W. Luo, L. Zhou, W. Yong, F. Chen, C. Wu, Q. Chen, and X. Han Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma Exp. Hematol. 39 2011 558 569
41. P. Yue, Z.H. Gao, X. Xue, S.X. Cui, C.R. Zhao, Y. Yuan, Z. Yin, Y. Inagaki, N. Kokudo, W. Tang, and X.J. Qu Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway Eur. J. Cancer 47 2011 1115 1124
42. K.A. West, S.S. Castillo, and P.A. Dennis Activation of the PI3K/Akt pathway and chemotherapeutic resistance Drug Resist. Updat. 5 2002 234 248 (Pubitemid 36132805)
43. A. Efeyan, and M. Serrano p53: guardian of the genome and policeman of the oncogenes Cell Cycle 6 2007 1006 1010 (Pubitemid 46708570)
44. I. Horikawa, K. Fujita, and C.C. Harris p53 governs telomere regulation feedback too, via TRF2 Aging (Albany NY) 3 2011 26 32
45. S. Kraus, I. Naumov, and N. Arber COX-2 active agents in the chemoprevention of colorectal cancer Recent Results Cancer Res. 191 2013 95 103
46. K. Lalithakumari, A.V. Krishnaraju, K. Sengupta, G.V. Subbaraju, and A. Chatterjee Safety and toxicological evaluation of a novel, standardized 3-O-Acetyl-11-keto-beta-boswellic acid (AKBA)-enriched Boswellia serrata extract (5-Loxin(R)) Toxicol. Mech. Methods 16 2006 199 226